Recruitment

Recruitment Status
Terminated
Estimated Enrollment
10

Summary

Conditions
Purpura, Thrombocytopenic, Idiopathic
Type
Interventional
Phase
Phase 1
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Locations

Los Angeles, California
New York, New York
Los Angeles, California
New York, New York

Tracking Information

NCT #
NCT02009761
Collaborators
Not Provided
Investigators
Study Chair: Boehringer Ingelheim Boehringer Ingelheim